The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

NCT00799903 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15828

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Darapladib
DRUG: Placebo

Sponsor

GlaxoSmithKline